FDA approves new class of medication for schizophrenia patients
A new drug has been approved to treat schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral drug manufactured by Bristol-Myers Squibb of New Jersey. According to a press release, this is the first new class of treatment for brain disorders in decades. 5 […]
Reforming 340B vital for affordable medication for low-income patients
Time 340B Drug Pricing Program Established in 1992, the program was intended by Congress to help low-income and uninsured patients afford prescription drugs. Pharmaceutical companies that make drugs covered by Medicaid are required to participate in the program, which offers them to patients at a discount that averages 25 to 50 percent off the wholesale […]
Physicians Charged in Matthew Perry’s Death Can Still Prescribe Medication
Two doctors indicted for their love affairs friend Doctors are reportedly still allowed to prescribe the drug following the death of star Matthew Perry. Doctors Mark Chavez and Salvador Plascencia, who are accused of conspiring to supply Perry with ketamine, said they could prescribe the drug to any patient just as they did to the […]
Diabetes patients have access to first generic GLP-1 medication: ‘More accessible’
Ozempic, Wegovy and other GLP-1 drugs have been shown to reduce weight and Diabetes Management Demand has skyrocketed in recent years, making it difficult for some people to obtain the medicine. To clear up supply chain disruptions, the first-ever generic GLP-1, a replica of Victoza, was launched on June 25th. Victoza, manufactured by Novo Nordisk […]
Record numbers in England taking ADHD medication, NHS data shows | Attention deficit hyperactivity disorder
Record numbers of people in England are taking medication for ADHD, data shows, highlighting a surge in diagnoses. According to the latest NHS Business Services data, around 278,000 patients in England were prescribed central nervous system stimulants (CNS) and attention deficit hyperactivity disorder (ADHD) medications between April 2023 and March 2024. That equates to about […]